Digoxin and mortality in chronic heart failure

Lancet

Volumn 354, Issue 9183, 1999, Pages 1003-

  Lindsay, S J ^a   Kearney, M T ^a   Prescott, R J ^b   Fox, K A A ^b   Nolan, J ^c  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b S ^*  (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIGOXIN;

ARTICLE; CLINICAL TRIAL; DRUG FATALITY; DRUG SAFETY; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; MORTALITY; PRIORITY JOURNAL; SINUS RHYTHM;

EID: 0033581409     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)03815-5     Document Type: Article

References (5)

1. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 336:1997;525-533.
2. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 353:1999;9-13.
3. Effect of metroprolol CR/XL in chronic heart failure: metoprolol CR/LX randomised intervention trial in congestive heart failure (MERIT-HF). Lancet. 353:1999;2001-2007.
4. Nolan J., Batin P.D., Andrews R.et al. Prospective study of heart rate variability and mortality in chronic heart failure; results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart). Circulation. 398:1998;1510-1516.
5. Spargias K.S., Hall A.S., Ball S.H. Safety concerns about digoxin after acute myocardial infarction. Lancet. 354:1999;391-392.